▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Fastenal Q4 21 Earnings Conference Call At 10:00 AM ET

By RTTNews Staff Writer ✉ | Published: 1/19/2022 9:00 AM ET

Fastenal Co. (FAST) will host a conference call at 10:00 AM ET on Jan. 19, 2022, to discuss Q4 21 earnings results.

To access the live webcast, log on to https://investor.fastenal.com/events-and-presentations/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In June 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In April 2023

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In March 2023

Latest Updates on COVID-19

FDA Approves Pfizer's COVID-19 Pill Paxlovid

US Revokes Covid Vaccination Requirement For International Air Travel

SD Biosensor Recalls Certain COVID-19 At-Home Tests Distributed By Roche

Read More

COVID-19: Drugs in Development

RELATED NEWS

Fastenal Co. Profit Climbs In Q1, Beats estimates

Fastenal Q1 23 Earnings Conference Call At 9:00 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Boeing, NASA Further Delay Starliner Crew Flight Launch

Chervon Recalls EGO Power+ Cordless Brushless Hedge Trimmers

E.N.A. Meat Packing Recalls Frozen, Raw Lamb Products

Macy's, Dollar General Q1 Profits Decline

FDA Warns Retailers Against Illegal Sales Of Disposable E-cigarettes

Tillamook Recalls Certain Waffle Cone Swirl Ice Cream Packaged In Chocolate Peanut Butter Carton

Mattel Unveils New Barbie The Movie Collection

Rudolph's OnYums Onion Flavored Rings Sold At Dollar Tree Recalled

Krispy Kreme, Dunkin' To Offer Free Donuts On National Doughnut Day

Cricket Creek Farm Recalls Sophelise And Tobasi Cheeses

Carvana Up 12%; Gets 'notable S&P Global Ratings Upgrades"

Seagen To Be Acquired By Pfizer For $43 Bln

Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints

Constellation To Acquire NRG's 44% Stake In South Texas Project Electric Generating Station

AbbVie Says Upadacitinib 30 Mg Meets Primary Goals In SLE Patients In Mid-stage Study

Sanofi: Frexalimab Phase 2 Trial Meets Primary Goal In Relapsing Multiple Sclerosis

AstraZeneca's Lynparza Gets FDA Approval For BRCAm Prostate Cancer

U-Haul Holding Shares Down On Lower Earnings In Q4

Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

VEEVA SYSTEMS INC Q1 Profit Increases, beats estimates

AstraZeneca Announces Discontinuation Of IBD Development Programme For Brazikumab

Magnachip To Spin-off Display And Power Businesses Into Separate Entities

Constellation To Acquire NRG's 44% Stake In South Texas Project Electric Generating Station

MEI Pharma Promotes COO David Urso To Succeed Daniel Gold As President And CEO

Rocket Pharma Says EMA Grants PRIME Designation For RP-A501 Gene Therapy For Danon Disease

Former Wells Fargo Executive Tolstedt Agrees To Settle SEC Fraud Charges

Hormel Foods Reaffirms FY23 Outlook - Update

8x8 Names Samuel Wilson CEO

Svenska Handelsbanken To Sell Certain Operations In Finland

Hewlett Packard Enterprise Q2 Profit Increases, beats estimates

CAE Q4 Earnings Spike

Guy Carpenter To Buy Israeli Insurance Broker Re Solutions For Undisclosed Sum

Dechra Pharma Agrees To Be Acquired By EQT's Freya Bidco For 3,875p/share In Cash

WH Smith 13-week Group Revenue Rises; Says Full-year Expectations Modestly Improved